DUBLIN--(BUSINESS WIRE)--Aug 24, 2018--The "Pharmacokinetics Services Market Size, Share & Trends Analysis Report By Drug Type (Small Molecules, Large Molecules (Biopharmaceuticals)), By Region, Competitive Landscape, And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

The global pharmacokinetics services market size is expected to reach USD 1.2 billion by 2025, registering an 8.3% CAGR during the forecast period.

Rising adoption of pharmacokinetic and toxicology studies for determination of several parameters such as no-observed-effect levels (NOEL), human equivalent doses (HED) levels, and pharmacokinetic/pharmacodynamic (PK/PD) drivers are expected to fuel market growth.

Thorough understanding of the pharmacokinetic profile of a potential drug candidate plays a major role in the success of a drug discovery program. In addition to this, regulatory bodies have played a major role in the progress of this market through establishing defined guidelines for conducting PK studies. There are a substantial number of CROs engaged in conducting PK studies in accordance with relevant EMEA, ICH, FDA, GCP, and other regulatory guidelines.

Growing concern for effective implementation of PK services in the drug development process is anticipated to drive investments in this sector. Several conferences and certification courses are being conducted across the world to increase the understanding of various paradigms associated with pharmacokinetics application in clinical and preclinical drug development.

Key Topics Covered:

Chapter 1 Executive Summary

Chapter 2 Research Methodology

Chapter 3 Pharmacokinetics Services Market Variables, Trends & Scope

Chapter 4 Pharmacokinetics Services Market: Drug Type Estimates & Trend Analysis

Chapter 5 Pharmacokinetics Services Market: Regional Estimates & Trend Analysis, by Drug Type

Chapter 6 Competitive Landscape

Evotec AG Certara, L.P. Pacific BioLabs GVK Biosciences Private Limited Shanghai Medicilon Inc. Pharmaceutical Product Development, LLC Charles River Laboratories International, Inc. PAREXEL International Corporation Eurofins Scientific, Inc. Frontage Labs SGS SA LGC Limited Creative Bioarray

For more information about this report visit https://www.researchandmarkets.com/research/cfx7vk/pharmacokinetics?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180824005214/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Drug Discovery

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/24/2018 09:26 AM/DISC: 08/24/2018 09:26 AM

http://www.businesswire.com/news/home/20180824005214/en